自身免疫性疾病中的乌比奎丁类蛋白:当前证据和治疗机会
Beomgu Lee1, Hoim Jeong1, Yerin Kim1
1Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea.
Immune network
|July 7, 2025
概括
乌比基类蛋白 (UBLs) 对于细胞过程和免疫系统功能至关重要. 本综述探讨了UBL如何促进自身免疫性疾病的发展,提供新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 自身免疫性疾病正在增加,目前的治疗方法会导致免疫抑制和副作用.
- 现有的疗法可以抑制炎症,但不能解决根本原因.
- 了解受影响细胞中的分子机制对于新疗法至关重要.
研究的目的:
- 审查在自身免疫性疾病的发展中无类蛋白质 (UBLs) 的作用.
- 为了突出UBL参与免疫系统调节.
- 提供关于自身免疫性疾病分子基础的见解.
主要方法:
- 文献综述侧重于泛素和泛素类蛋白质.
- 分析UBL在细胞平衡和免疫反应中的功能.
- 确定涉及自身免疫性疾病的特定UBLs.
主要成果:
- 乌比奎丁对于通过E1-E2-E3级联来实现细胞平衡至关重要.
- 一些UBL,包括SUMO,ISG15,Nedd8和HLTF,调节免疫过程.
- 这些UBL在免疫系统和疾病发病过程中起着不同的作用.
结论:
- UBLs是免疫系统的关键调节者,并与自身免疫性疾病有关.
- 了解UBL功能为自身免疫性疾病的发展提供了新的分子洞察力.
- 准UBL通路可能会导致更有效的自身免疫性疾病治疗方法.
相关概念视频
Autoimmune Disorders
679
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
679
Inflammatory Bowel Disease IV: Pharmacological Management
200
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
200
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
238
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
238
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
Covalently Linked Protein Regulators
7.3K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.3K


